Circulation, Vol 74, 1290-1302, Copyright © 1986 by American Heart Association
MB Fowler, JA Laser, GL Hopkins, W Minobe and MR Bristow
We developed methods for identifying beta-adrenergic receptors in human
right ventricular endomyocardial biopsy tissue with the radioligand (-
)[125I]iodocyanopindolol (ICYP). Specific ICYP binding in a crude, high-
yield membrane preparation derived from endomyocardial biopsy tissue was
high (specificity greater than 90%), of high affinity (KD around 20 pM),
saturable and stereospecific for the (-) vs the (+) isomer of
isoproterenol. Subjects with mild-moderate and severe biventricular
dysfunction had respective decreases in beta-adrenergic receptor density of
38.2% and 57.7% when normalization methods were averaged, with no
significant differences in ICYP dissociation constant. A subgroup of
subjects was subdivided by left ventricular ejection fraction (LVEF) into
those with mild cardiac dysfunction (LVEF less than 0.50 greater than 0.40)
and severe heart failure (LVEF less than 0.20) and given graded sequential
infusions of dobutamine and calcium gluconate. Those with severe cardiac
dysfunction had marked impairment of the dobutamine dP/dt and stroke work
index response, whereas these responses to calcium did not differ in the
two groups. These data indicate that in the intact human heart
endomyocardial biopsy may be used for direct analysis of beta-adrenergic
receptors, heart failure- associated myocardial beta-adrenergic
down-regulation begins with mild- moderate ventricular dysfunction,
reduction in myocardial beta-receptor density is related to degree of heart
failure, and beta-receptor down- regulation is associated with
pharmacologically specific impairment of the beta-agonist-mediated
contractile response.
ARTICLES
Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response
This article has been cited by other articles:
![]() |
T. Tsukamoto, K. Morita, M. Naya, M. Inubushi, C. Katoh, K. Nishijima, Y. Kuge, H. Okamoto, H. Tsutsui, and N. Tamaki Decreased Myocardial {beta}-Adrenergic Receptor Density in Relation to Increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy J. Nucl. Med., November 1, 2007; 48(11): 1777 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Krishnamurthy, V. Subramanian, M. Singh, and K. Singh {beta}1 Integrins Modulate {beta}-Adrenergic Receptor-Stimulated Cardiac Myocyte Apoptosis and Myocardial Remodeling Hypertension, April 1, 2007; 49(4): 865 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Otasevic, Z B Popovic, J D Vasiljevic, L Pratali, A Vlahovic-Stipac, S D Boskovic, N Tasic, and A N Neskovic Head-to-head comparison of indices of left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in idiopathic dilated cardiomyopathy: five-year follow up Heart, September 1, 2006; 92(9): 1253 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Senzaki, S. Masutani, H. Ishido, M. Taketazu, T. Kobayashi, N. Sasaki, H. Asano, T. Katogi, S. Kyo, and Y. Yokote Cardiac Rest and Reserve Function in Patients With Fontan Circulation J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2528 - 2535. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Kallergis, E. G. Manios, E. M. Kanoupakis, S. E. Schiza, H. E. Mavrakis, N. K. Klapsinos, and P. E. Vardas Acute Electrophysiologic Effects of Inhaled Salbutamol in Humans Chest, June 1, 2005; 127(6): 2057 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
P G Camici Coronary recanalisation, myocardial viability, and ventricular remodelling after infarction Heart, April 1, 2005; 91(4): 421 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Duncker, D. B. Haitsma, D. A. Liem, P. D. Verdouw, and D. Merkus Exercise unmasks autonomic dysfunction in swine with a recent myocardial infarction Cardiovasc Res, March 1, 2005; 65(4): 889 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology Eur. Heart J., February 2, 2005; 26(4): 384 - 416. [Full Text] [PDF] |
||||
![]() |
B. F. McBride and C. M. White Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET J. Clin. Pharmacol., January 1, 2005; 45(1): 6 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakayama, X. Yan, R. L. Price, T. K. Borg, K. Ito, A. Sanbe, J. Robbins, and B. H. Lorell Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H317 - H327. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Torre-Amione, F. Sestier, B. Radovancevic, and J. Young Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: Results of a randomized, controlled, phase II trial J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1181 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Pogwizd, K. R Sipido, F. Verdonck, and D. M Bers Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis Cardiovasc Res, March 15, 2003; 57(4): 887 - 896. [Full Text] [PDF] |
||||
![]() |
N. Spyrou, S. D. Rosen, F. Fath-Ordoubadi, R. Jagathesan, R. Foale, J. S. Kooner, and P. G. Camici Myocardial beta-adrenoceptor densityone month after acute myocardial infarctionpredicts left ventricular volumes at six months J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1216 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Metra, S. Nodari, A. D'Aloia, C. Muneretto, A. D. Robertson, M. R. Bristow, and L. Dei Cas Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1248 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Senzaki, S. Masutani, J. Kobayashi, T. Kobayashi, N. Sasaki, H. Asano, S. Kyo, Y. Yokote, and A. Ishizawa Ventricular Afterload and Ventricular Work in Fontan Circulation: Comparison With Normal Two-Ventricle Circulation and Single-Ventricle Circulation With Blalock-Taussig Shunts Circulation, June 18, 2002; 105(24): 2885 - 2892. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.F. Notarius, E.R. Azevedo, J.D. Parker, and J.S. Floras Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure Eur. Heart J., May 2, 2002; 23(10): 800 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Delforge, D. Mesangeau, F. Dolle, P. Merlet, C. Loc'h, M. Bottlaender, R. Trebossen, and A. Syrota In Vivo Quantification and Parametric Images of the Cardiac {beta}-Adrenergic Receptor Density J. Nucl. Med., February 1, 2002; 43(2): 215 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A Nikolaidis, T. Hentosz, A. Doverspike, R. Huerbin, C. Stolarski, Y.-T. Shen, and R. P Shannon Catecholamine stimulation is associated with impaired myocardial O2 utilization in heart failure Cardiovasc Res, February 1, 2002; 53(2): 392 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Houle, R. A. Altschuld, and G. E. Billman Enhanced in vivo and in vitro contractile responses to {beta}2-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias J Appl Physiol, October 1, 2001; 91(4): 1627 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Burger, M. Benicke, A. Deten, and H.-G. Zimmer Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H14 - H21. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.M Ramahi, M.D Longo, A.R Cadariu, K Rohlfs, M Slade, S Carolan, E Vallejo, and F.J.T. Wackers Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy Eur. Heart J., May 2, 2001; 22(10): 849 - 856. [Abstract] [PDF] |
||||
![]() |
T. M. Ramahi, M. D. Longo, A. R. Cadariu, K. Rohlfs, S. A. Carolan, K. M. Engle, H. Samady, and F. J. T. Wackers Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy J. Am. Coll. Cardiol., March 1, 2001; 37(3): 818 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bristow Of Phospholamban, Mice, and Humans With Heart Failure Circulation, February 13, 2001; 103(6): 787 - 788. [Full Text] [PDF] |
||||
![]() |
R. J. Lefkowitz and J. T. Willerson Prospects for Cardiovascular Research JAMA, February 7, 2001; 285(5): 581 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Muro, T Ota, H Watanabe, M Teragaki, K Takeuchi, and J Yoshikawa Prediction of contractile reserve by cyclic variation of integrated backscatter of the myocardium in patients with chronic left ventricular dysfunction Heart, February 1, 2001; 85(2): 165 - 170. [Abstract] [Full Text] |
||||
![]() |
L. Eklund, J. Piuhola, J. Komulainen, R. Sormunen, C. Ongvarrasopone, R. Fässler, A. Muona, M. Ilves, H. Ruskoaho, T. E. S. Takala, et al. Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice PNAS, January 23, 2001; (2001) 31444798. [Abstract] [Full Text] |
||||
![]() |
R Schulz and G Heusch Hibernating myocardium Heart, December 1, 2000; 84(6): 587 - 594. [Full Text] |
||||
![]() |
K. Isaaz What are we actually measuring by Doppler tissue imaging? J. Am. Coll. Cardiol., September 1, 2000; 36(3): 897 - 899. [Full Text] [PDF] |
||||
![]() |
B. D. Lowes, M. Higginbotham, L. Petrovich, M. A. DeWood, M. A. Greenberg, P. S. Rahko, G. W. Dec, T. H. LeJemtel, R. L. Roden, M. M. Schleman, et al. Low-dose enoximone improves exercise capacity in chronic heart failure J. Am. Coll. Cardiol., August 1, 2000; 36(2): 501 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Scrutinio, V Napoli, A Passantino, A Ricci, R Lagioia, and P Rizzon Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome Eur. Heart J., June 1, 2000; 21(11): 927 - 934. [Abstract] [PDF] |
||||
![]() |
W. W. Brooks, O. H. L. Bing, M. O. Boluyt, A. Malhotra, J. P. Morgan, N. Satoh, W. S. Colucci, and C. H. Conrad Altered Inotropic Responsiveness and Gene Expression of Hypertrophied Myocardium With Captopril Hypertension, June 1, 2000; 35(6): 1203 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Recchia, R. D. Bernstein, P. B. Sehgal, N. R. Ferreri, and T. H. Hintze Cytokines Are Not a Requisite Part of the Pathophysiology Leading to Cardiac Decompensation Experimental Biology and Medicine, January 1, 2000; 223(1): 47 - 52. [Abstract] [Full Text] |
||||
![]() |
F. Sakamaki, T. Satoh, N. Nagaya, S. Kyotani, N. Nakanishi, and Y. Ishida Abnormality of Left Ventricular Sympathetic Nervous Function Assessed by 123I-Metaiodobenzylguanidine Imaging in Patients With COPD* Chest, December 1, 1999; 116(6): 1575 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Billington, I. P. Hall, S. J. Mundell, J.-L. Parent, R. A. Panettieri Jr., J. L. Benovic, and R. B. Penn Inflammatory and Contractile Agents Sensitize Specific Adenylyl Cyclase Isoforms in Human Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., November 1, 1999; 21(5): 597 - 606. [Abstract] [Full Text] |
||||
![]() |
S. Sandmann, J.-Y. Min, A. Meissner, and T. Unger Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca2+-handling in infarct-induced heart failure in rats Cardiovasc Res, October 1, 1999; 44(1): 67 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Feldman and C. McTiernan New Insight Into the Role of Enhanced Adrenergic Receptor-Effector Coupling in the Heart Circulation, August 10, 1999; 100(6): 579 - 582. [Full Text] [PDF] |
||||
![]() |
J. Wattanapermpool and P. J. Reiser Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H467 - H473. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Dorn II, N. M. Tepe, J. N. Lorenz, W. J. Koch, and S. B. Liggett Low- and high-level transgenic expression of beta 2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galpha q-overexpressing mice PNAS, May 25, 1999; 96(11): 6400 - 6405. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Kukin, J. Kalman, R. H. Charney, D. K. Levy, C. Buchholz-Varley, O. N. Ocampo, and C. Eng Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure Circulation, May 25, 1999; 99(20): 2645 - 2651. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O'Rourke, D. A. Kass, G. F. Tomaselli, S. Kaab, R. Tunin, and E. Marban Mechanisms of Altered Excitation-Contraction Coupling in Canine Tachycardia-Induced Heart Failure, I : Experimental Studies Circ. Res., March 19, 1999; 84(5): 562 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Hartmann, S Ziegler, S Nekolla, M Hadamitzky, M Seyfarth, G Richardt, and M Schwaiger Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography Heart, March 1, 1999; 81(3): 262 - 270. [Abstract] [Full Text] |
||||
![]() |
K. Asai, M. Uechi, N. Sato, W. Shen, T. Meguro, M. A. Mathier, R. P. Shannon, and S. F. Vatner Lack of desensitization and enhanced efficiency of calcium channel promoter in conscious dogs with heart failure Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2219 - H2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mardon, P. Merlet, A. Syrota, and B. Maziere Effects of 5-day hypoxia on cardiac adrenergic neurotransmission in rats J Appl Physiol, September 1, 1998; 85(3): 890 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Vroom Pharmacologic Management of Acute Heart Failure: A Review Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 191 - 203. [Abstract] [PDF] |
||||
![]() |
C Mittmann, T Eschenhagen, and H Scholz Cellular and molecular aspects of contractile dysfunction in heart failure Cardiovasc Res, August 1, 1998; 39(2): 267 - 275. [Full Text] [PDF] |
||||
![]() |
M. L. Dickstein Anesthesia for Heart Transplantation Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1998; 2(2): 131 - 139. [Abstract] [PDF] |
||||
![]() |
T. Nozawa, A. Igawa, N. Yoshida, M. Maeda, M. Inoue, Y. Yamamura, H. Asanoi, and H. Inoue Dual-Tracer Assessment of Coupling Between Cardiac Sympathetic Neuronal Function and Downregulation of ß-Receptors During Development of Hypertensive Heart Failure of Rats Circulation, June 16, 1998; 97(23): 2359 - 2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Sullebarger, P. M. D'Ambra, L. C. Clark, L. Thanikarry, and H. L. Fontanet Effect of Digoxin on Ventricular Remodeling and Responsiveness of {beta}-Adrenoceptors in Chronic Volume Overload Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(4): 281 - 290. [Abstract] [PDF] |
||||
![]() |
S. Yamada, T. Ohkura, T. Yamadera, O. Ito, R. Kimura, Y. Nozawa, S. Hayashi, and H. Miyake Abnormality in Plasma Catecholamines and Myocardial Adrenoceptors in Cardiomyopathic BIO 53.58 Syrian Hamsters and Improvement by Metoprolol Treatment J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1389 - 1395. [Abstract] [Full Text] |
||||
![]() |
M. L Kukin, J. Kalman, M. M Mannino, C. Buchholz-Varley, and O. Ocampo beta Blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses Heart, November 1, 1997; 78(5): 444 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Billman, L. C. Castillo, J. Hensley, C. M. Hohl, and R. A. Altschuld ß2-Adrenergic Receptor Antagonists Protect Against Ventricular Fibrillation : In Vivo and In Vitro Evidence for Enhanced Sensitivity to ß2-Adrenergic Stimulation in Animals Susceptible to Sudden Death Circulation, September 16, 1997; 96(6): 1914 - 1922. [Abstract] [Full Text] |
||||
![]() |
G. S. Bodor, A. E. Oakeley, P. D. Allen, D. L. Crimmins, J. H. Ladenson, and P. A. W. Anderson Troponin I Phosphorylation in the Normal and Failing Adult Human Heart Circulation, September 2, 1997; 96(5): 1495 - 1500. [Abstract] [Full Text] |
||||
![]() |
N. Sato, S. F. Vatner, Y.-T. Shen, R. K. Kudej, B. Ghaleh-Marzban, M. Uechi, K. Asai, I. Mirsky, T. A. Patrick, R. P. Shannon, et al. Effects of Cardiac Denervation on Development of Heart Failure and Catecholamine Desensitization Circulation, April 15, 1997; 95(8): 2130 - 2140. [Abstract] [Full Text] |
||||
![]() |
S. Teramura, T. Yamakado, M. Maeda, and T. Nakano Effects of MCI-154, a Calcium Sensitizer, on Left Ventricular Systolic and Diastolic Function in Pacing-Induced Heart Failure in the Dog Circulation, February 4, 1997; 95(3): 732 - 739. [Abstract] [Full Text] |
||||
![]() |
J. Gorcsan III, S. Murali, P. J. Counihan, W. A. Mandarino, and R. L. Kormos Right Ventricular Performance and Contractile Reserve in Patients With Severe Heart Failure: Assessment by Pressure-Area Relations and Association With Outcome Circulation, December 15, 1996; 94(12): 3190 - 3197. [Abstract] [Full Text] |
||||
![]() |
E. M. Gilbert, W. T. Abraham, S. Olsen, B. Hattler, M. White, P. Mealy, P. Larrabee, and M. R. Bristow Comparative Hemodynamic, Left Ventricular Functional, and Antiadrenergic Effects of Chronic Treatment With Metoprolol Versus Carvedilol in the Failing Heart Circulation, December 1, 1996; 94(11): 2817 - 2825. [Abstract] [Full Text] |
||||
![]() |
W. C. De Mello Impaired Regulation of Cell Communication by ß-Adrenergic Receptor Activation in the Failing Heart Hypertension, February 1, 1996; 27(2): 265 - 268. [Abstract] [Full Text] |
||||
![]() |
H. B. Bittner, E. P. Chen, C. A. Milano, S. W.H. Kendall, R. B. Jennings, D. C. Sabiston Jr, and P. Van Trigt Myocardial ß-Adrenergic Receptor Function and High-Energy Phosphates in Brain Death– Related Cardiac Dysfunction Circulation, November 1, 1995; 92(9): 472 - 478. [Abstract] [Full Text] |
||||
![]() |
|